Qiu Y, Galiñanes M, Ferrari R, Cargnoni A, Ezrin A, Hearse D J
Rayne Institute, St. Thomas' Hospital, London, United Kingdom.
Am J Physiol. 1992 Oct;263(4 Pt 2):H1243-9. doi: 10.1152/ajpheart.1992.263.4.H1243.
The isolated blood-perfused rabbit heart, subjected to 60 min of cardioplegic arrest and 60 min of reperfusion, was used to assess the effects of polyethylene glycol-conjugated superoxide dismutase (PEG-SOD) on postischemic recovery of left ventricular developed pressure (LVDP), the tissue activity of SOD, and tissue redox state. The five groups studied were the following: PEG-SOD-free control (group A), PEG-SOD as a pretreatment and as an additive during cardioplegia and reperfusion (group B), PEG-SOD as a pretreatment and a cardioplegic additive (group C), PEG-SOD in cardioplegia alone (group D), and PEG-SOD in reperfusion alone (group E). The results show that pretreatment with PEG-SOD improves postischemic recovery of LVDP (72 +/- 2% and 66 +/- 7 vs. 47 +/- 4% in groups B, C, and A, respectively). This protection was associated with an improved tissue redox state. Thus the ischemia-induced rise in oxidized glutathione was reduced from 313 +/- 26% (group A) to 162 +/- 15 and 138 +/- 14% (groups B and C, respectively), and the fall in reduced glutathione was attenuated from 51 +/- 5% to 35 +/- 6 and 13 +/- 5%, respectively. Tissue Mn-SOD activity was also conserved from 36 +/- 4% (group A) to 71 +/- 6 and 94 +/- 4% (groups B and C, respectively). No significant effect was seen when PEG-SOD was applied in cardioplegia or during reperfusion alone.
采用离体血液灌注兔心,使其经历60分钟心脏停搏和60分钟再灌注,以评估聚乙二醇结合超氧化物歧化酶(PEG-SOD)对左心室舒张末压(LVDP)缺血后恢复、超氧化物歧化酶组织活性及组织氧化还原状态的影响。所研究的五组如下:无PEG-SOD的对照组(A组)、在心脏停搏和再灌注期间作为预处理及添加剂的PEG-SOD(B组)、作为预处理及心脏停搏添加剂的PEG-SOD(C组)、仅在心脏停搏时使用的PEG-SOD(D组)以及仅在再灌注时使用的PEG-SOD(E组)。结果显示,PEG-SOD预处理可改善LVDP的缺血后恢复(B组、C组和A组分别为72±2%、66±7%和47±4%)。这种保护作用与改善的组织氧化还原状态相关。因此,缺血诱导的氧化型谷胱甘肽升高从313±26%(A组)降至162±15%和138±14%(分别为B组和C组),还原型谷胱甘肽的降低从51±5%分别减轻至35±6%和13±5%。组织锰超氧化物歧化酶活性也从36±4%(A组)分别保留至71±6%和94±4%(B组和C组)。单独在心脏停搏或再灌注时应用PEG-SOD未观察到显著效果。